MedPath
TGA Approval

NBL Royal Jelly EX (381249)

381249

NBL Royal Jelly EX

Macro Enterprise Australia Pty Ltd

December 22, 2021

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

Royal jelly lyophilised

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NBL Royal Jelly EX (381249) - TGA 批准文号 | MedPath